Patient-derived xenografts for individualized care in advanced sarcoma

BACKGROUND: Patients with advanced, metastatic sarcoma have a poor prognosis, and the overall benefit from the few standard-of-care therapeutics available is small. The rarity of this tumor, combined with the wide range of subtypes, leads to difficulties in conducting clinical trials. The authors pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Stebbing, Justin, Paz, Keren, Schwartz, Gary K, Wexler, Leonard H, Maki, Robert, Pollock, Raphael E, Morris, Ronnie, Cohen, Richard, Shankar, Arjun, Blackman, Glen, Harding, Victoria, Vasquez, David, Krell, Jonathan, Ciznadija, Daniel, Katz, Amanda, Sidransky, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298787/
https://www.ncbi.nlm.nih.gov/pubmed/24705963
http://dx.doi.org/10.1002/cncr.28696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298787/
https://www.ncbi.nlm.nih.gov/pubmed/24705963
http://dx.doi.org/10.1002/cncr.28696

Ejemplares similares